AI assistant
Pluri Inc. — Director's Dealing 2015
Jan 8, 2015
6990_rns_2015-01-09_641874a9-7567-4be1-b6e2-bcb13b2cb8b9.pdf
Director's Dealing
Open in viewerOpens in your device viewer
FORM 4
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
☐ Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b).
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
| OMB APPROVAL | |
|---|---|
| OMB Number: | 3235-0287 |
| Expires: | December 31, 2014 |
| Estimated average burden hours per response | 0.5 |
| 1. Name and Address of Reporting Person* | |
| ROSMAN NACHUM 0001415890 | |
| PLURISTEM THERAPEUTICS | |
| INC [PSTI] | 5. Relationship of Reporting Person(s) to Issuer |
| (Check all applicable) | |
| ☑ Director 10% Owner | |
| Officer (give title below) Other (specify below) | |
| --- | --- |
| (Last) | (First) |
| 7 FINESTEIN ST. | |
| 01/08/2015 | |
| (Street) | |
| (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) |
| ☑ Form filed by One Reporting Person | |
| Form filed by More than One Reporting Person | |
| TEL-AVIV | L3 |
| (City) | (State) |
| Table I – Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | |
| --- | --- |
| 1. Title of Security (Instr. 3) | 2. Transaction Date |
| (Month/Day/Year) | 2A. Deemed Execution Date, if any |
| (Month/Day/Year) | 3. Transaction Code (Instr. 8) |
| Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) |
| Common Stock | 01/08/2015(1) |
| Table II – Derivative Securities Acquired, Disposed of, or Beneficially Owned | |
| (e.g., puts, calls, warrants, options, convertible securities) | |
| --- | --- |
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security |
| (Month/Day/Year) | 3A. Deemed Execution Date, if any |
| (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
| (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) |
| Code | V |
Explanation of Responses:
- The shares vest as follows: 25% after 6 months from grant and the remaining shares vest in 6 equal installments every 3 months thereafter.
Remarks:
/s/ Nachum Rosman
01/08/2015
** Signature of Reporting Person
Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
- If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.